CAH logo

Cardinal Health, Inc. Stock Price

NYSE:CAH Community·US$36.7b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 55 Fair Values set on narratives written by author

CAH Share Price Performance

US$155.19
43.43 (38.86%)
14.0% undervalued intrinsic discount
US$180.46
Fair Value
US$155.19
43.43 (38.86%)
13.7% undervalued intrinsic discount
US$179.93
Fair Value
Price US$155.19
AnalystConsensusTarget US$179.93

CAH Community Narratives

AnalystConsensusTarget·
Fair Value US$180.46 14.0% undervalued intrinsic discount

Global Pharmaceutical Demand And Automation Will Expand Distribution Reach

0users have liked this narrative
0users have commented on this narrative
29users have followed this narrative

Recent CAH News & Updates

Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5107

Sep 23
Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5107

Here's Why We Think Cardinal Health (NYSE:CAH) Might Deserve Your Attention Today

Jul 28
Here's Why We Think Cardinal Health (NYSE:CAH) Might Deserve Your Attention Today

Investors Still Waiting For A Pull Back In Cardinal Health, Inc. (NYSE:CAH)

Jun 20
Investors Still Waiting For A Pull Back In Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health, Inc. Key Details

US$222.6b

Revenue

US$214.4b

Cost of Revenue

US$8.2b

Gross Profit

US$6.6b

Other Expenses

US$1.6b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 30, 2025
Earnings per share (EPS)
6.57
Gross Margin
3.67%
Net Profit Margin
0.70%
Debt/Equity Ratio
-317.7%

Cardinal Health, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Solid track record, good value and pays a dividend.

2 Risks
3 Rewards

About CAH

Founded
1979
Employees
55392
CEO
Jason Hollar
WebsiteView website
www.cardinalhealth.com

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 1.1%
  • 3 Months: 8.9%
  • 1 Year: 18.9%
  • Year to Date: 15.1%
The market is up 1.1% over the last week, with the Information Technology sector leading the way, up 1.9%. In the last year, the market has climbed 19%. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›